Information:
Fel:
ID
28336
Beskrivning
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Nyckelord
Versioner (2)
- 2017-11-30 2017-11-30 -
- 2018-01-04 2018-01-04 -
Rättsinnehavare
Prof. Dr. med. Georg Heß
Uppladdad den
4 januari 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Screening Registration GOAL Trial B-cell Lymphoma NCT02499003
Screening Registration GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Similar models
Screening Registration GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
compliance inclusion criteria
Item
Subject complies with all inclusion criteria?
boolean
C1321605 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C1512693 (UMLS CUI [1,2])
compliance exclusion criteria
Item
Subject complies with all exclusion criteria?
boolean
C1321605 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
C0680251 (UMLS CUI [1,2])
Inclusion in study
Item
Include subject into study?
boolean
C1512693 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])
Patient number
Item
Patient No.
integer
C1830427 (UMLS CUI [1])